ChainCatcher news, according to businesswire, Nasdaq-listed biotechnology company Equillium announced the launch of a cryptocurrency reserve strategy, integrating the cryptocurrency funding reserve strategy as part of its broader financial and growth objectives.

As of June 30, 2025, the company's total cash and cash equivalents amount to approximately $11.5 million, and it has not yet disclosed which digital currencies it will purchase.